{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T03:19:38Z","timestamp":1782789578907,"version":"3.54.5"},"reference-count":27,"publisher":"American Association for the Advancement of Science (AAAS)","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T00:00:00Z","timestamp":1655251200000},"content-version":"vor","delay-in-days":165,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["csbj.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comput Struct Biotechnol J"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.csbj.2022.06.039","type":"journal-article","created":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T11:40:18Z","timestamp":1655552418000},"page":"3106-3119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment acrossmultiplecancers"],"prefix":"10.34133","volume":"20","author":[{"given":"Ning","family":"Wang","sequence":"first","affiliation":[{"name":"Division of Pulmonary Medicine, The First Affiliated Hospital of Wenzhou Medical University, Key Laboratory of Heart and Lung, Wenzhou, Zhejiang 325000, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingye","family":"Zhu","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Medicine, The First Affiliated Hospital of Wenzhou Medical University, Key Laboratory of Heart and Lung, Wenzhou, Zhejiang 325000, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangxing","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Medicine, The First Affiliated Hospital of Wenzhou Medical University, Key Laboratory of Heart and Lung, Wenzhou, Zhejiang 325000, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifa","family":"Shen","sequence":"additional","affiliation":[{"name":"Key Laboratory of Laboratory Medicine, Ministry of Education of China, Zhejiang Provincial Key Laboratory of Medical Genetics, School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Huang","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Medicine, The First Affiliated Hospital of Wenzhou Medical University, Key Laboratory of Heart and Lung, Wenzhou, Zhejiang 325000, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","published-online":{"date-parts":[[2022,6,21]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"crossref","first-page":"854","DOI":"10.2174\/1568009619666190620114928","article-title":"The Role of Shcbp1 in Signaling and Disease","volume":"19","author":"Zhang G.Y.","year":"2019","unstructured":"Zhang G.Y., Ma Z.J., Wang L. et al: The Role of Shcbp1 in Signaling and Disease. Curr Cancer Drug Targets 2019; 19: 854.","journal-title":"Curr Cancer Drug Targets"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-018-0473-z"},{"key":"e_1_3_4_4_2","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1080\/15384047.2020.1824512","article-title":"FGF13 interaction with SHCBP1 activates AKT-GSK3\u03b1\/\u03b2 signaling and promotes the proliferation of A549 cells","volume":"21","author":"Lu H.","year":"2020","unstructured":"Lu H., Yin M., Wang L. et al: FGF13 interaction with SHCBP1 activates AKT-GSK3\u03b1\/\u03b2 signaling and promotes the proliferation of A549 cells. Cancer Biol Ther 2020; 21: 1014.","journal-title":"Cancer Biol Ther"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.116798"},{"key":"e_1_3_4_6_2","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1038\/s41467-021-23053-8","article-title":"Hyperactivation of HER2-SHCBP1-PLK1 axis promotes tumor cell mitosis and impairs trastuzumab sensitivity to gastric cancer","volume":"12","author":"Shi W.","year":"2021","unstructured":"Shi W., Zhang G., Ma Z. et al: Hyperactivation of HER2-SHCBP1-PLK1 axis promotes tumor cell mitosis and impairs trastuzumab sensitivity to gastric cancer. Nat Commun 2021; 12: 2812.","journal-title":"Nat Commun"},{"key":"e_1_3_4_7_2","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.ygeno.2021.01.010","article-title":"SHCBP1 interacting with EOGT enhances O-GlcNAcylation of NOTCH1 and promotes the development of pancreatic cancer","volume":"113","author":"Yang C.","year":"2021","unstructured":"Yang C., Hu J.F., Zhan Q. et al: SHCBP1 interacting with EOGT enhances O-GlcNAcylation of NOTCH1 and promotes the development of pancreatic cancer. Genomics 2021; 113: 827.","journal-title":"Genomics"},{"key":"e_1_3_4_8_2","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.613879","article-title":"SHCBP1 Promotes Papillary Thyroid Carcinoma Carcinogenesis and Progression Through Promoting Formation of Integrin and Collagen and Maintaining Cell Stemness","volume":"11","author":"Geng H.","year":"2020","unstructured":"Geng H., Guo M., Xu W. et al: SHCBP1 Promotes Papillary Thyroid Carcinoma Carcinogenesis and Progression Through Promoting Formation of Integrin and Collagen and Maintaining Cell Stemness. Front Endocrinol (Lausanne) 2020; 11: 613879.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"e_1_3_4_9_2","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1002\/mc.22834","article-title":"Overexpression of SHCBP1 promotes migration and invasion in gliomas by activating the NF-\u03baB signaling pathway","volume":"57","author":"Zhou Y.","year":"2018","unstructured":"Zhou Y., Tan Z., Chen K. et al: Overexpression of SHCBP1 promotes migration and invasion in gliomas by activating the NF-\u03baB signaling pathway. Mol Carcinog 2018; 57: 1181.","journal-title":"Mol Carcinog"},{"key":"e_1_3_4_10_2","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1038\/s41467-020-18514-5","article-title":"The shared frameshift mutation landscape of microsatellite-unstable cancers suggests immunoediting during tumor evolution","volume":"11","author":"Ballhausen A.","year":"2020","unstructured":"Ballhausen A., Przybilla M.J., Jendrusch M. et al: The shared frameshift mutation landscape of microsatellite-unstable cancers suggests immunoediting during tumor evolution. Nat Commun 2020; 11: 4740.","journal-title":"Nat Commun"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-1372"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14273-0"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-12-0095"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2004088"},{"key":"e_1_3_4_15_2","doi-asserted-by":"crossref","unstructured":"Warde-Farley D Donaldson SL Comes O et al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 2010. 38(Web Server issue): W214-20.","DOI":"10.1093\/nar\/gkq537"},{"key":"e_1_3_4_16_2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s13312-011-0055-4","article-title":"Receiver operating characteristic (ROC) curve for medical researchers","volume":"48","author":"Kumar R.","year":"2011","unstructured":"Kumar R. and Indrayan A.: Receiver operating characteristic (ROC) curve for medical researchers. Indian Pediatr 2011; 48: 277.","journal-title":"Indian Pediatr"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2017.101"},{"key":"e_1_3_4_18_2","doi-asserted-by":"crossref","first-page":"6684","DOI":"10.1002\/jcp.29564","article-title":"SOX2-induced upregulation of lncRNA LINC01561 promotes non-small-cell lung carcinoma progression by sponging miR-760 to modulate SHCBP1 expression","volume":"235","author":"Gao W.","year":"2020","unstructured":"Gao W., Qi C.Q., Feng M.G., Yang P., Liu L. and Sun S.H.: SOX2-induced upregulation of lncRNA LINC01561 promotes non-small-cell lung carcinoma progression by sponging miR-760 to modulate SHCBP1 expression. J Cell Physiol 2020; 235: 6684.","journal-title":"J Cell Physiol"},{"key":"e_1_3_4_19_2","first-page":"3138","article-title":"SHCBP1 regulates STAT3\/c-Myc signaling activation to promote tumor progression in penile cancer","volume":"10","author":"Mo M.","year":"2020","unstructured":"Mo M., Tong S., Yin H., Jin Z., Zu X. and Hu X.: SHCBP1 regulates STAT3\/c-Myc signaling activation to promote tumor progression in penile cancer. Am J Cancer Res 2020; 10: 3138.","journal-title":"Am J Cancer Res"},{"key":"e_1_3_4_20_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.106123","article-title":"Oroxylin A inhibits carcinogen-induced skin tumorigenesis through inhibition of inflammation by regulating SHCBP1 in mice","volume":"80","author":"Huang H.","year":"2020","unstructured":"Huang H., Cai H., Zhang L., Hua Z., Shi J. and Wei Y.: Oroxylin A inhibits carcinogen-induced skin tumorigenesis through inhibition of inflammation by regulating SHCBP1 in mice. Int Immunopharmacol 2020; 80: 106123.","journal-title":"Int Immunopharmacol"},{"key":"e_1_3_4_21_2","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1007\/s00432-020-03247-1","article-title":"SHCBP1 promotes tumor cell proliferation, migration, and invasion, and is associated with poor prostate cancer prognosis","volume":"146","author":"Xu N.","year":"2020","unstructured":"Xu N., Wu Y.P., Yin H.B. et al: SHCBP1 promotes tumor cell proliferation, migration, and invasion, and is associated with poor prostate cancer prognosis. J Cancer Res Clin Oncol 2020; 146: 1953.","journal-title":"J Cancer Res Clin Oncol"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-17-0987"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2019.01.010"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18731-y"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-019-0370-y"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2018.10.022"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-2033"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18919-2"}],"container-title":["Computational and Structural Biotechnology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037022002537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2001037022002537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/spj.science.org\/doi\/pdf\/10.1016\/j.csbj.2022.06.039","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T13:00:12Z","timestamp":1779022812000},"score":1,"resource":{"primary":{"URL":"https:\/\/spj.science.org\/doi\/10.1016\/j.csbj.2022.06.039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":27,"alternative-id":["10.1016\/j.csbj.2022.06.039"],"URL":"https:\/\/doi.org\/10.1016\/j.csbj.2022.06.039","relation":{},"ISSN":["2001-0370"],"issn-type":[{"value":"2001-0370","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment acrossmultiplecancers","name":"articletitle","label":"Article Title"},{"value":"Computational and Structural Biotechnology Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.csbj.2022.06.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology.","name":"copyright","label":"Copyright"}]}}